Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000517519 | SCV000612509 | pathogenic | not provided | 2023-03-30 | criteria provided, single submitter | clinical testing | The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in individuals with familial hemiplegic migraine (FHM) and/or cerebellar ataxia (PMID: 24498617, 17142831, 11439943, 12707077). This variant segregates with disease in multiple families. Assessment of experimental evidence suggests this variant results in abnormal protein function. This variant leads to altered calcium channel function (PMID: 10734061). |
Institute of Medical Genetics and Applied Genomics, |
RCV000517519 | SCV001447183 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001380080 | SCV001578023 | pathogenic | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2022-08-12 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 8505). For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects CACNA1A function (PMID: 10734061). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CACNA1A protein function. This missense change has been observed in individuals with CACNA1A-related conditions (PMID: 12707077, 20837964, 24498617, 26814174). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs121908217, gnomAD 0.0009%). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 583 of the CACNA1A protein (p.Arg583Gln). |
Revvity Omics, |
RCV000517519 | SCV002018029 | pathogenic | not provided | 2021-08-16 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000517519 | SCV002067465 | pathogenic | not provided | 2020-03-26 | criteria provided, single submitter | clinical testing | |
Wendy Chung Laboratory, |
RCV002227018 | SCV002506544 | pathogenic | Episodic ataxia type 2; Spinocerebellar ataxia type 6; Migraine, familial hemiplegic, 1; Developmental and epileptic encephalopathy, 52 | 2022-03-20 | criteria provided, single submitter | clinical testing | |
Genetics and Molecular Pathology, |
RCV000009030 | SCV002761927 | pathogenic | Spinocerebellar ataxia type 6 | 2022-07-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000517519 | SCV003845502 | pathogenic | not provided | 2023-03-22 | criteria provided, single submitter | clinical testing | Published functional studies show that the R583Q variant affects the voltage-gated calcium ion channel (Kraus et al., 2000); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 12707077, 12056940, 18056581, 19624685, 22527033, 30078120, 32888184, 30710491, 32626992, 10408534, 23407676, 11439943, 10734061, 28717674, 25969684, 24498617, 28900389, 33084218, 26814174, 35401678) |
Mayo Clinic Laboratories, |
RCV000517519 | SCV004225072 | pathogenic | not provided | 2023-04-19 | criteria provided, single submitter | clinical testing | PP1, PP2, PP3, PS3, PS4 |
OMIM | RCV000009028 | SCV000029244 | pathogenic | Migraine, familial hemiplegic, 1 | 2003-04-01 | no assertion criteria provided | literature only | |
OMIM | RCV000009029 | SCV000029246 | pathogenic | Sporadic hemiplegic migraine | 2003-04-01 | no assertion criteria provided | literature only | |
OMIM | RCV000009030 | SCV000029247 | pathogenic | Spinocerebellar ataxia type 6 | 2003-04-01 | no assertion criteria provided | literature only | |
Uni |
RCV000009028 | SCV000090841 | not provided | Migraine, familial hemiplegic, 1 | no assertion provided | not provided | ||
Gene |
RCV001533158 | SCV001748977 | not provided | Familial hemiplegic migraine | no assertion provided | literature only | ||
O&I group, |
RCV000009030 | SCV001960824 | pathogenic | Spinocerebellar ataxia type 6 | 2021-07-22 | no assertion criteria provided | research |